Story perspectives

Controversial DNA Profiling for Babies Sparks Ethical Debate

11/29/2025

Summary

Story summary

Nucleus Genomics, a New York start-up, offers embryo DNA profiling for $8,999 to genetically optimize future babies, claiming it can reduce disease risk and predict traits.
Critics, including behavioral geneticists, label this approach as eugenics and raise ethical concerns.
Experts say genetics is improving, but polygenic risk scores lack proven clinical benefits.
A recent ad campaign boosted sales by 1700%, though it remains unclear if any couples used the service.

1 of 1

Story summary

Nucleus Genomics, a New York start-up, offers embryo DNA profiling for $8,999 to genetically optimize future babies, claiming it can reduce disease risk and predict traits.
Critics, including behavioral geneticists, label this approach as eugenics and raise ethical concerns.
Experts say genetics is improving, but polygenic risk scores lack proven clinical benefits.
A recent ad campaign boosted sales by 1700%, though it remains unclear if any couples used the service.